Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples